With an initial seed investment of $12 million, Optain becomes the first company announced in Ascertain's growing portfolio of AI companies.
Called ORAiCLE, it can assess the cardiovascular risk of an individual through a retinal scan, more accurately than the current gold standard.
Under the strategic partnership, DAI will use its extensive international network to bring ThinkMD's digital health products to new markets.
The device and its companion app turn pretty much any smartphone into a portable colposcope, making the screening process available all around the world.
The smart mole scanner, which is designed to be attached to a smartphone's camera, is now live on crowdfunding website Indiegogo.
The D3 system consists of a small device that attaches to the smartphone's camera to convert it into a microscope which can analyze a sample of a few cells.
Researchers at the Johns Hopkins University School of Medicine have developed a handheld device that can pick up vital signs from a patient's lips and fingertip.
The model would allow healthcare providers to predict the spread of influenza from one person to the next over time, and turn this into actionable information.
Called Hoope, it has a retractable needle and functions as a home diagnostic tool that distributes blood into four microfluidic channels and to a lab-on-a-chip.
Called My Health Discovery, the application asks the right questions in order to have more realistic and accurate goals for improving one's lifestyle.